Cargando…
A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation
Duchenne muscular dystrophy (DMD), caused by mutations in the X-linked dystrophin gene, is a lethal neuromuscular disease. Correction of DMD mutations in animal models has been achieved by CRISPR/Cas9 genome editing using Streptococcus pyogenes Cas9 (SpCas9) delivered by adeno-associated virus (AAV)...
Autores principales: | Zhang, Yu, Nishiyama, Takahiko, Li, Hui, Huang, Jian, Atmanli, Ayhan, Sanchez-Ortiz, Efrain, Wang, Zhaoning, Mireault, Alex A., Mammen, Pradeep P.A., Bassel-Duby, Rhonda, Olson, Eric N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397837/ https://www.ncbi.nlm.nih.gov/pubmed/34485599 http://dx.doi.org/10.1016/j.omtm.2021.05.014 |
Ejemplares similares
-
Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
por: Zhang, Yu, et al.
Publicado: (2020) -
A humanized knockin mouse model of Duchenne muscular dystrophy and its correction by CRISPR-Cas9 therapeutic gene editing
por: Zhang, Yu, et al.
Publicado: (2022) -
Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
por: Chemello, F., et al.
Publicado: (2021) -
Single-swap editing for the correction of common Duchenne muscular dystrophy mutations
por: Chai, Andreas C., et al.
Publicado: (2023) -
In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse
por: Amoasii, Leonela, et al.
Publicado: (2019)